 | • レポートコード：MRC-IM30204 • 出版社/出版日：IMARC / 2022年10月 • レポート形態：英文、PDF、146ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥374,850 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥674,850 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| IMARC社の調査レポートによると、世界の分子細胞遺伝学市場規模は2021年に22億ドルに達しました。今後、2027年には40億ドルになり、2022年から2022年の間に年平均10.32％成長すると予測しています。本調査レポートでは、分子細胞遺伝学の世界市場について調査・分析を行い、序論、調査範囲・手法、エグゼクティブサマリー、イントロダクション、製品種類別（機器、消耗品、ソフトウェア＆サービス、その他）分析、技術別（ゲノムハイブリダイゼーション、FISH、免疫組織化学、核型分析、その他）分析、用途別（遺伝性疾患、腫瘍、個別化医療、その他）分析、エンドユーザー別（臨床＆研究所、病院＆病理検査室、製薬＆バイオテクノロジー企業、その他）分析、地域別（北米、アジア、欧州、中南米、中東・アフリカ）分析、SWOT分析（強み・弱み・機会・脅威）、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などを掲載しています。なお、企業情報には、Abbott Laboratories, Agilent Technologies Inc., Applied Spectral Imaging Inc., Biological Industries, Bio-RAD Laboratories Inc., BioView Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Illumina Inc., Oxford Gene Technology, Perkinelmer Inc. and Quest Diagnostics Incorporated.などが含まれています。 ・序論 ・調査範囲・手法 ・エグゼクティブサマリー ・イントロダクション ・世界の分子細胞遺伝学市場規模：製品種類別 - 機器の市場規模 - 消耗品の市場規模 - ソフトウェア＆サービスの市場規模 - その他製品の市場規模 ・世界の分子細胞遺伝学市場規模：技術別 - ゲノムハイブリダイゼーション技術の市場規模 - FISH技術の市場規模 - 免疫組織化学技術の市場規模 - 核型分析技術の市場規模 - その他技術の市場規模 ・世界の分子細胞遺伝学市場規模：用途別 - 遺伝性疾患用分子細胞遺伝学の市場規模 - 腫瘍用分子細胞遺伝学の市場規模 - 個別化医療用分子細胞遺伝学の市場規模 - その他用途の市場規模 ・世界の分子細胞遺伝学市場規模：エンドユーザー別 - 臨床＆研究所における市場規模 - 病院＆病理検査室における市場規模 - 製薬＆バイオテクノロジー企業における市場規模 - その他エンドユーザーにおける市場規模 ・世界の分子細胞遺伝学市場規模：地域別 - 北米の分子細胞遺伝学市場規模 - アジアの分子細胞遺伝学市場規模 - 欧州の分子細胞遺伝学市場規模 - 中南米の分子細胞遺伝学市場規模 - 中東・アフリカの分子細胞遺伝学市場規模 ・SWOT分析（強み・弱み・機会・脅威） ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global molecular cytogenetics market size reached US$ 2.2 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4.0 Billion by 2027, exhibiting a growth rate (CAGR) of 10.32% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Molecular cytogenetics refers to the biomedical research of deoxyribonucleic acid (DNA) mechanisms to investigate genetic mutations and disorders. It studies the structural and functional organization of the chromosomes and their nucleus, genomic variations, expression, evolution and abnormalities, especially in medicinal and cancer-related genetics. Techniques such as DNA amplification, DNA isolation, gene screens, virtual karyotyping and fluorescence in situ hybridization (FISH) are commonly used for molecular cytogenetics by using DNA probes to visualize and label the genome or its targeted regions. These techniques are highly beneficial in the diagnosis and treatment of various malignant tumors and hematological malignancies.
The increasing prevalence of cancer and other genetic disorders, along with the rising geriatric population, is one of the key factors driving the growth of the market. Molecular cytogenetics is primarily being used for developing predictive models of disease traits and effective treatment strategies. Furthermore, the widespread adoption of targeted therapies for cancer treatment is also augmenting the market growth. FISH and Comparative Genomic Hybridization (CGH) are also used for pharmacogenomic biomarker studies to analyze cancer progression stages and provide personalized treatment to the patient. Additionally, various technological advancements, such as the development of improved consumables, reagents, software and kits, are acting as other growth-inducing factors. These advancements aid in generating duplicatable, accurate and reliable clinical-pathological test results. Other factors, including significant improvements in the healthcare infrastructure, along with extensive research and development (R&D) activities in the field of biomedical sciences, are anticipated to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global molecular cytogenetics market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type, technology, application and end user.
Breakup by Product Type:
Instruments
Consumables
Software and Services
Others
Breakup by Technology:
Comparative Genomic Hybridization
Fluorescence in SITU Hybridization (FISH)
Immunohistochemistry
Karyotyping
Others
Breakup by Application:
Genetic Disorders
Oncology
Personalized Medicine
Others
Breakup by End User:
Clinical and Research Laboratories
Hospitals and Pathology Laboratories
Pharmaceutical and Biotechnology Companies
Others
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Agilent Technologies Inc., Applied Spectral Imaging Inc., Biological Industries, Bio-RAD Laboratories Inc., BioView Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Illumina Inc., Oxford Gene Technology, Perkinelmer Inc. and Quest Diagnostics Incorporated.
Key Questions Answered in This Report:
How has the global molecular cytogenetics market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global molecular cytogenetics market?
What are the key regional markets?
What is the breakup of the market based on the product type?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global molecular cytogenetics market and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Molecular Cytogenetics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product Type
6.1 Instruments
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Consumables
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Software and Services
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Others
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Technology
7.1 Comparative Genomic Hybridization
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Fluorescence in SITU Hybridization (FISH)
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Immunohistochemistry
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Karyotyping
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Application
8.1 Genetic Disorders
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Oncology
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Personalized Medicine
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by End User
9.1 Clinical and Research Laboratories
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Hospitals and Pathology Laboratories
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Abbott Laboratories
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Agilent Technologies Inc.
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 Applied Spectral Imaging Inc.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 Biological Industries
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 Bio-RAD Laboratories Inc.
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.5.3 Financials
15.3.5.4 SWOT Analysis
15.3.6 BioView Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 Danaher Corporation
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 F. Hoffmann-La Roche AG
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.8.3 SWOT Analysis
15.3.9 Illumina Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.9.3 Financials
15.3.9.4 SWOT Analysis
15.3.10 Oxford Gene Technology
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.10.3 Financials
15.3.11 Perkinelmer Inc.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 Quest Diagnostics Incorporated
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
Figure 2: Global: Molecular Cytogenetics Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Molecular Cytogenetics Market: Breakup by Product Type (in %), 2021
Figure 4: Global: Molecular Cytogenetics Market: Breakup by Technology (in %), 2021
Figure 5: Global: Molecular Cytogenetics Market: Breakup by Application (in %), 2021
Figure 6: Global: Molecular Cytogenetics Market: Breakup by End User (in %), 2021
Figure 7: Global: Molecular Cytogenetics Market: Breakup by Region (in %), 2021
Figure 8: Global: Molecular Cytogenetics Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 9: Global: Molecular Cytogenetics (Instruments) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Molecular Cytogenetics (Instruments) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Molecular Cytogenetics (Consumables) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Molecular Cytogenetics (Consumables) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Molecular Cytogenetics (Software and Services) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Molecular Cytogenetics (Software and Services) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Molecular Cytogenetics (Other Product Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Molecular Cytogenetics (Other Product Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Molecular Cytogenetics (Comparative Genomic Hybridization) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Molecular Cytogenetics (Comparative Genomic Hybridization) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: Global: Molecular Cytogenetics (Fluorescence in SITU Hybridization - FISH) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: Global: Molecular Cytogenetics (Fluorescence in SITU Hybridization - FISH) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Global: Molecular Cytogenetics (Immunohistochemistry) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Global: Molecular Cytogenetics (Immunohistochemistry) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Global: Molecular Cytogenetics (Karyotyping) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Global: Molecular Cytogenetics (Karyotyping) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Global: Molecular Cytogenetics (Other Technologies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Global: Molecular Cytogenetics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Global: Molecular Cytogenetics (Genetic Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Global: Molecular Cytogenetics (Genetic Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: Global: Molecular Cytogenetics (Oncology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: Global: Molecular Cytogenetics (Oncology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: Global: Molecular Cytogenetics (Personalized Medicine) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: Global: Molecular Cytogenetics (Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: Global: Molecular Cytogenetics (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: Global: Molecular Cytogenetics (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: Global: Molecular Cytogenetics (Clinical and Research Laboratories) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: Global: Molecular Cytogenetics (Clinical and Research Laboratories) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: Global: Molecular Cytogenetics (Hospitals and Pathology Laboratories) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: Global: Molecular Cytogenetics (Hospitals and Pathology Laboratories) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: Global: Molecular Cytogenetics (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: Global: Molecular Cytogenetics (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: Global: Molecular Cytogenetics (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: Global: Molecular Cytogenetics (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: North America: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: North America: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 45: United States: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 46: United States: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 47: Canada: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 48: Canada: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Asia Pacific: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Asia Pacific: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 51: China: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 52: China: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 53: Japan: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 54: Japan: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: India: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: India: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 57: South Korea: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 58: South Korea: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 59: Australia: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 60: Australia: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Indonesia: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Indonesia: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 63: Others: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 64: Others: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 65: Europe: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 66: Europe: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Germany: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Germany: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 69: France: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 70: France: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 71: United Kingdom: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 72: United Kingdom: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Italy: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Italy: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: Spain: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 76: Spain: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Russia: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 78: Russia: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Others: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 80: Others: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 81: Latin America: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 82: Latin America: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 83: Brazil: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 84: Brazil: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Mexico: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 86: Mexico: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 87: Others: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 88: Others: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 89: Middle East and Africa: Molecular Cytogenetics Market: Sales Value (in Million US$), 2016 & 2021
Figure 90: Middle East and Africa: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 91: Global: Molecular Cytogenetics Industry: SWOT Analysis
Figure 92: Global: Molecular Cytogenetics Industry: Value Chain Analysis
Figure 93: Global: Molecular Cytogenetics Industry: Porter’s Five Forces Analysis